Eine Tageszeitung (Symbolbild).
Dienstag, 08.09.2015 16:05 von | Aufrufe: 605

Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against XOMA Corporation and Lead Plaintiff Deadline September 22, 2015

Eine Tageszeitung (Symbolbild). pixabay.com

PR Newswire

NEW YORK, Sept. 8, 2015 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed in the United States District Court for the Northern District of California on behalf of those who purchased shares of XOMA Corporation ("XOMA" or the "Company") (NasdaqGM: XOMA), during the period between November 6, 2014 and July 21, 2015 inclusive. (the "Class Period").

The Lawsuit alleges that throughout the Class Period, defendants made false and/or misleading statements that Xoma Corporation's EYEGUARD-B clinical trial would succeed and/or surpass expectations across the study's primary endpoint. On July 22, 2015, defendants revealed that the Phase 3 EYEGUARD-B study had failed.

Following this news, the price of XOMA stock declined by $3.48 per share, or over 79%, on extremely heavy trading volume.

No Class has yet been certified in the above action. If you wish to review a copy of the Complaint, to discuss this action, or have any questions, please contact Peretz Bronstein, Esq. or his Investor Relations Coordinator Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number.  If you suffered a loss in Xoma you have until September 22, 2015 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman 212-697-6484
info@bgandg.com


ARIVA.DE Börsen-Geflüster

Kurse

25,08 $
-1,10%
Xoma Corp Chart

SOURCE Bronstein, Gewirtz & Grossman, LLC

Werbung

Mehr Nachrichten zur Xoma Corp Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News